PLAVIX Side Effects

7023630-X | Amnesia, Aphasia, Asthenia, Balance Disorder, Confusional State, Dysarthria, Dysstasia, Fatigue, Heart Rate Irregular
on Sep 30, 2010 Female patient from UNITED STATES , 16 years of age, weighting 146.4 lb, was treated with Plavix (View Usage). Patient experienced the following unwanted or unexpected effects: amnesia, aphasia (What is aphasia?), asthenia, balance disorder, confusional state, dysarthria, dysstasia, fatigue, heart rate irregular. Plavix dosage: 75mg Plavix Once Daily Orally. During the same period patient was treated with GORE HELEX CARDIAC SEPTAL OCCULER (View Gore Helex Cardiac Septal Occuler Review and Gore Helex Cardiac Septal Occuler Label ), MEDROXYPROGESTERONE (View Medroxyprogesterone Review and Medroxyprogesterone Label ).

7022345-1 | Asthenia, Gait Disturbance, Influenza Like Illness
Patient was taking Plavix (View Usage). Patient had the following side effects: asthenia, gait disturbance, influenza like illness on Sep 20, 2010 from UNITED STATES Additional patient health information: Male patient , 83 years of age, weighting 160.9 lb, was diagnosed with stent placement and. Plavix dosage: . During the same period patient was treated with NORVASC (View Norvasc Review and Norvasc Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ).

7022342-6 | Arterial Occlusive Disease, Condition Aggravated, Contusion, Off Label Use, Pain, Renal Artery Stenosis
Adverse event was reported on Sep 20, 2010 by a Female patient taking Plavix (View Usage) (Dosage: ) was diagnosed with renal artery stenosis and. Location: UNITED STATES , 63 years of age, After Plavix was administered, patient had the following side effects: arterial occlusive disease, condition aggravated, contusion, off label use, pain (What is pain?), renal artery stenosis. During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ).

7022222-6 | Dermatitis Exfoliative, Purpura
on Sep 20, 2010 Male patient from ITALY , 63 years of age, was diagnosed with renal failure and was treated with Plavix (View Usage). Patient experienced the following unwanted or unexpected effects: dermatitis exfoliative, purpura. Plavix dosage: . During the same period patient was treated with CARDIOASPIRIN (View Cardioaspirin Review and Cardioaspirin Label ), TRIATEC (View Triatec Review and Triatec Label ), LASIX (View Lasix Review and Lasix Label ), SEACOR (View Seacor Review and Seacor Label ), KLACID (View Klacid Review and Klacid Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ).


7021530-2 | Pulmonary Embolism
on Sep 24, 2010 Female patient from TUNISIA , 61 years of age, was diagnosed with stent placement, diabetes mellitus and was treated with Plavix (View Usage). Patient had the following side effects: pulmonary embolism (What is pulmonary embolism?). Plavix dosage: . During the same period patient was treated with ASPEGIC 1000 (View Aspegic 1000 Review and Aspegic 1000 Label ), CORVASAL (View Corvasal Review and Corvasal Label ), LOSARTAN POTASSIUM (View Losartan Potassium Review and Losartan Potassium Label ), INSULIN (View Insulin Review and Insulin Label ).

7019575-1 | Hospitalisation
Patient was taking Plavix (View Usage). After Plavix was administered, patient had the following side effects: hospitalisation on Sep 28, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 130.5 lb, was diagnosed with cerebrovascular accident prophylaxis, transient ischaemic attack and. Plavix dosage: . Patient was hospitalized.

7018252-0 | Gastrooesophageal Reflux Disease
Adverse event was reported on Sep 16, 2010 by a Male patient taking Plavix (View Usage) (Dosage: ) . Location: UNITED STATES , 84 years of age, Patient experienced the following unwanted or unexpected effects: gastrooesophageal reflux disease. During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), BETA BLOCKING AGENTS (View Beta Blocking Agents Review and Beta Blocking Agents Label ), HMG COA REDUCTASE INHIBITORS (View Hmg Coa Reductase Inhibitors Review and Hmg Coa Reductase Inhibitors Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ). Patient was hospitalized.

7018168-X | Abdominal Pain, Abdominal Pain Upper, Decreased Appetite, Gastritis, Nausea
on Sep 20, 2010 Female patient from GERMANY , 83 years of age, was diagnosed with peripheral arterial occlusive disease and was treated with Plavix (View Usage). Patient had the following side effects: abdominal pain (What is abdominal pain?), abdominal pain upper, decreased appetite, gastritis, nausea (What is nausea?). Plavix dosage: Unit Dose: 75 Mg. During the same period patient was treated with BISOPROLOL FUMARATE (Unit Dose: 2.5 Mg) (View Bisoprolol Fumarate Review and Bisoprolol Fumarate Label ), JATROSOM N (Dose Text: 20-10-0 Mg Daily) (View Jatrosom N Review and Jatrosom N Label ), OMEPRAZOLE (Unit Dose: 20 Mg) (View Omeprazole Review and Omeprazole Label ), QUILONUM (Unit Dose: 225 Mg) (View Quilonum Review and Quilonum Label ). Patient was hospitalized.

7018012-0 | Gastric Ulcer
on Sep 20, 2010 Female patient from SWEDEN , 67 years of age, was diagnosed with myocardial infarction and was treated with Plavix (View Usage). After Plavix was administered, patient had the following side effects: gastric ulcer. Plavix dosage: . During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), NOVORAPID (Dose:100 International Unit(s)/millilitre) (View Novorapid Review and Novorapid Label ), ATORVASTATIN CALCIUM (View Atorvastatin Calcium Review and Atorvastatin Calcium Label ), EZETROL (View Ezetrol Review and Ezetrol Label ), INSULIN DETEMIR (Dose:100 International Unit(s)/millilitre) (View Insulin Detemir Review and Insulin Detemir Label ), RAMIPRIL (View Ramipril Review and Ramipril Label ), ZOPICLONE (View Zopiclone Review and Zopiclone Label ), NITROLINGUAL (View Nitrolingual Review and Nitrolingual Label ). Patient was hospitalized.

7017994-0 | Arterial Occlusive Disease, Embolic Stroke, Visual Field Defect
Patient was taking Plavix (View Usage). Patient experienced the following unwanted or unexpected effects: arterial occlusive disease, embolic stroke, visual field defect on Sep 17, 2010 from UNITED STATES Additional patient health information: Male patient , 86 years of age, weighting 175.0 lb, . Plavix dosage: . During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), IRON (View Iron Review and Iron Label ).

7017969-1 | Pancytopenia, Pneumonia, White Blood Cell Count Decreased
Adverse event was reported on Sep 17, 2010 by a Male patient taking Plavix (View Usage) (Dosage: ) was diagnosed with constipation (What is constipation?), hypertension, reflux oesophagitis and. Location: JAPAN , 82 years of age, weighting 121.3 lb, Patient had the following side effects: pancytopenia, pneumonia (What is pneumonia?), white blood cell count decreased. During the same period patient was treated with ALPHA ADRENORECEPTOR ANTAGONISTS (View Alpha-adrenoreceptor Antagonists Review and Alpha-adrenoreceptor Antagonists Label ), GASMOTIN (View Gasmotin Review and Gasmotin Label ), MICARDIS (View Micardis Review and Micardis Label ), LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ), AMLODIPINE BESYLATE (View Amlodipine Besylate Review and Amlodipine Besylate Label ), FAMOTIDINE (View Famotidine Review and Famotidine Label ).

7017960-5 | Carotid Artery Occlusion, Condition Aggravated, Loss Of Consciousness, Off Label Use
on Sep 17, 2010 Female patient from UNITED STATES , 47 years of age, was diagnosed with stent placement and was treated with Plavix (View Usage). After Plavix was administered, patient had the following side effects: carotid artery occlusion, condition aggravated, loss of consciousness, off label use. Plavix dosage: . During the same period patient was treated with CLOPIDOGREL (View Clopidogrel Review and Clopidogrel Label ), PRAVACHOL (View Pravachol Review and Pravachol Label ), ZESTRIL (View Zestril Review and Zestril Label ), CELEXA (View Celexa Review and Celexa Label ).

7015200-4 | Laboratory Test Abnormal, Malaise, Oedema Peripheral, Oxygen Saturation Decreased, Thrombosis
on Sep 17, 2010 Female patient from UNITED STATES , weighting 130.1 lb, was treated with Plavix (View Usage). Patient experienced the following unwanted or unexpected effects: laboratory test abnormal, malaise, oedema peripheral, oxygen saturation decreased, thrombosis. Plavix dosage: . During the same period patient was treated with TAMOXIFEN CITRATE (View Tamoxifen Citrate Review and Tamoxifen Citrate Label ), COUMADIN (View Coumadin Review and Coumadin Label ), DIOVAN (View Diovan Review and Diovan Label ), CLONIDINE (View Clonidine Review and Clonidine Label ). Patient was hospitalized.

7015039-X | Tendon Rupture
Patient was taking Plavix (View Usage). Patient had the following side effects: tendon rupture on Sep 16, 2010 from GERMANY Additional patient health information: Male patient , 64 years of age, was diagnosed with infarction, acute coronary syndrome and. Plavix dosage: .

7014823-6 | Tendon Rupture
Adverse event was reported on Sep 10, 2010 by a Male patient taking Plavix (View Usage) (Dosage: ) was diagnosed with infarction, acute coronary syndrome and. Location: GERMANY , 80 years of age, After Plavix was administered, patient had the following side effects: tendon rupture.

7013844-7 | Asthenia, Back Disorder, Contusion, Fatigue, Pain In Extremity
on Sep 15, 2010 Male patient from UNITED STATES , 66 years of age, was diagnosed with stent placement and was treated with Plavix (View Usage). Patient experienced the following unwanted or unexpected effects: asthenia, back disorder, contusion, fatigue, pain in extremity. Plavix dosage: . During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ).

7013843-5 | Carotid Artery Occlusion, Incorrect Dose Administered
on Sep 15, 2010 Male patient from UNITED STATES , 72 years of age, was treated with Plavix (View Usage). Patient had the following side effects: carotid artery occlusion, incorrect dose administered. Plavix dosage: Quarter Of A Tablet Once Daily. During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ).

7013814-9 | Asthenia, Blood Pressure Systolic Increased, Erectile Dysfunction, Insomnia, Productive Cough, Weight Decreased
Patient was taking Plavix (View Usage). After Plavix was administered, patient had the following side effects: asthenia, blood pressure systolic increased, erectile dysfunction (What is erectile dysfunction?), insomnia, productive cough, weight decreased on Sep 14, 2010 from UNITED STATES Additional patient health information: Male patient , 71 years of age, weighting 149.9 lb, . Plavix dosage: . During the same period patient was treated with MICRONASE (View Micronase Review and Micronase Label ), COZAAR (View Cozaar Review and Cozaar Label ).

7013050-6 | Blepharal Papilloma, Blood Pressure Increased, Cardiac Failure Congestive, Condition Aggravated, Erythema, Fatigue, Headache, Heart Rate Increased, Skin Haemorrhage
Adverse event was reported on Sep 15, 2010 by a Male patient taking Plavix (View Usage) (Dosage: ) . Location: UNITED STATES , 70 years of age, Patient experienced the following unwanted or unexpected effects: blepharal papilloma, blood pressure increased, cardiac failure congestive, condition aggravated, erythema, fatigue, headache (What is headache?), heart rate increased, skin haemorrhage. During the same period patient was treated with DIGOXIN (View Digoxin Review and Digoxin Label ), NITROGLYCERIN ^SLOVAKOFARMA^ (View Nitroglycerin ^slovakofarma^ Review and Nitroglycerin ^slovakofarma^ Label ), CARVEDILOL (View Carvedilol Review and Carvedilol Label ). Patient was hospitalized.

7012500-9 | Contusion, Diarrhoea, Erythema, Faeces Discoloured, Pruritus, Rash
on Sep 23, 2010 Female patient from UNITED STATES , weighting 151.0 lb, was diagnosed with peripheral arterial occlusive disease and was treated with Plavix (View Usage). Patient had the following side effects: contusion, diarrhoea, erythema, faeces discoloured, pruritus, rash (What is rash?). Plavix dosage: .

7010973-9 | Epistaxis, Multiple Myeloma
on Sep 22, 2010 Male patient from UNITED STATES , weighting 140.0 lb, was diagnosed with prophylaxis and was treated with Plavix (View Usage). After Plavix was administered, patient had the following side effects: epistaxis, multiple myeloma (What is multiple myeloma?). Plavix dosage: 75 Mg Tablet Daily Po.

7010892-8 | Asthenia, Confusional State, Cough, Erectile Dysfunction, Gait Disturbance, Insomnia, Sexual Dysfunction, Weight Decreased
Patient was taking Plavix (View Usage). Patient experienced the following unwanted or unexpected effects: asthenia, confusional state, cough, erectile dysfunction (What is erectile dysfunction?), gait disturbance, insomnia, sexual dysfunction, weight decreased on Sep 23, 2010 from UNITED STATES Additional patient health information: Male patient , 71 years of age, weighting 126.3 lb, was diagnosed with cerebrovascular accident and. Plavix dosage: 75 Mgs Once In The Morning Once Daily.

7010581-X | Gastrointestinal Haemorrhage, Myocardial Infarction
Adverse event was reported on Sep 20, 2010 by a Female patient taking Plavix (View Usage) (Dosage: ) . Location: UNITED STATES , 72 years of age, weighting 249.1 lb, Patient had the following side effects: gastrointestinal haemorrhage, myocardial infarction.

7010546-8 | Pruritus, Rash Pustular
on Sep 14, 2010 Female patient from FRANCE , 79 years of age, was diagnosed with coronary arterial stent insertion, osteoporosis (What is osteoporosis?) and was treated with Plavix (View Usage). After Plavix was administered, patient had the following side effects: pruritus, rash pustular. Plavix dosage: . During the same period patient was treated with LASIX (View Lasix Review and Lasix Label ), BISOPROLOL FUMARATE (View Bisoprolol Fumarate Review and Bisoprolol Fumarate Label ), PERINDOPRIL (View Perindopril Review and Perindopril Label ), ELISOR (View Elisor Review and Elisor Label ), KARDEGIC (View Kardegic Review and Kardegic Label ), ESOMEPRAZOLE MAGNESIUM (View Esomeprazole Magnesium Review and Esomeprazole Magnesium Label ), STRONTIUM RANELATE (View Strontium Ranelate Review and Strontium Ranelate Label ), IOXAGLATE MEGLUMINE/IOXAGLATE SODIUM (View Ioxaglate Meglumine/ioxaglate Sodium Review and Ioxaglate Meglumine/ioxaglate Sodium Label ). Patient was hospitalized.

7010530-4 | Prostate Cancer
on Sep 10, 2010 Male patient from UNITED STATES , 66 years of age, was diagnosed with stent placement and was treated with Plavix (View Usage). Patient experienced the following unwanted or unexpected effects: prostate cancer (What is prostate cancer?). Plavix dosage: .

7010521-3 | Cerebral Haemorrhage, Cerebral Infarction, Coagulopathy, Coma, Gingival Bleeding, Headache, Occult Blood, Purpura
Patient was taking Plavix (View Usage). Patient had the following side effects: cerebral haemorrhage, cerebral infarction, coagulopathy, coma, gingival bleeding, headache (What is headache?), occult blood, purpura on Sep 14, 2010 from CHINA Additional patient health information: Female patient , weighting 176.4 lb, was diagnosed with myocardial infarction and. Plavix dosage: . During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), HEPARIN SODIUM (View Heparin Sodium Review and Heparin Sodium Label ). Patient was hospitalized.

7009964-3 |
Adverse event was reported on Sep 16, 2010 by a Male patient taking Plavix (View Usage) (Dosage: ) was diagnosed with acute myocardial infarction, prophylaxis and. Location: JAPAN , 68 years of age, weighting 119.0 lb, . During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), OLMETEC (View Olmetec Review and Olmetec Label ), GASTER D (View Gaster D Review and Gaster D Label ), NOVORAPID (4 Iu In The Morning, 8 Iu At Noon And 4 Iu In The Evening.) (View Novorapid Review and Novorapid Label ), INSULIN DETEMIR (8 Iu Before Sleep.) (View Insulin Detemir Review and Insulin Detemir Label ).

7009948-5 | Angina Pectoris, Cardiac Disorder, Gait Disturbance, Pain In Extremity
on Sep 13, 2010 Male patient from UNITED STATES , 83 years of age, was treated with Plavix (View Usage). Patient experienced the following unwanted or unexpected effects: angina pectoris, cardiac disorder, gait disturbance, pain in extremity. Plavix dosage: . During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), ZOCOR (View Zocor Review and Zocor Label ). Patient was hospitalized.

7008724-7 | Bleeding Time Prolonged, Gait Disturbance, Muscular Weakness
on Sep 10, 2010 Male patient from UNITED STATES , 90 years of age, weighting 159.8 lb, was diagnosed with prostate cancer (What is prostate cancer?) and was treated with Plavix (View Usage). Patient had the following side effects: bleeding time prolonged, gait disturbance, muscular weakness. Plavix dosage: Unit Dose: 75 Mg. During the same period patient was treated with TOPROL XL (Dose Text: A Little Bit, Less Than What Is Prescribed) (View Toprol-xl Review and Toprol-xl Label ), AMIODARONE HCL (Dose Text: A Little Bit, Less Than Prescribed) (View Amiodarone Hcl Review and Amiodarone Hcl Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), LOVAZA (View Lovaza Review and Lovaza Label ), ZONEGRAN (View Zonegran Review and Zonegran Label ), HORMONE ANTAGONISTS AND RELATED AGENTS (View Hormone Antagonists And Related Agents Review and Hormone Antagonists And Related Agents Label ), SENOKOT /UNK/ (View Senokot /unk/ Review and Senokot /unk/ Label ), METAMUCIL 2 (View Metamucil-2 Review and Metamucil-2 Label ).

7008723-5 | Blood Creatine Phosphokinase Increased
Patient was taking Plavix (View Usage). After Plavix was administered, patient had the following side effects: blood creatine phosphokinase increased on Sep 08, 2010 from JAPAN Additional patient health information: Male patient , 59 years of age, was diagnosed with cerebral infarction and. Plavix dosage: . During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), ADALAT (View Adalat Review and Adalat Label ), TANATRIL ^TANABE^ (View Tanatril ^tanabe^ Review and Tanatril ^tanabe^ Label ), FERROMIA (View Ferromia Review and Ferromia Label ). Patient was hospitalized.

7004979-3 | Arterial Occlusive Disease, Embolic Stroke, Visual Field Defect
Adverse event was reported on Sep 09, 2010 by a Male patient taking Plavix (View Usage) (Dosage: ) . Location: UNITED STATES , 86 years of age, weighting 175.0 lb, Patient experienced the following unwanted or unexpected effects: arterial occlusive disease, embolic stroke, visual field defect. During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), IRON (View Iron Review and Iron Label ).

7004912-4 |
on Sep 09, 2010 Female patient from UNITED STATES , 56 years of age, was treated with Plavix (View Usage). . Plavix dosage: .

7004907-0 | Arrhythmia, Haemorrhage
on Sep 09, 2010 Female patient from UNITED STATES , 82 years of age, weighting 90.01 lb, was treated with Plavix (View Usage). After Plavix was administered, patient had the following side effects: arrhythmia (What is arrhythmia?), haemorrhage. Plavix dosage: . During the same period patient was treated with COUMADIN (View Coumadin Review and Coumadin Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), DRONEDARONE HCL (View Dronedarone Hcl Review and Dronedarone Hcl Label ), PRAVASTATIN (View Pravastatin Review and Pravastatin Label ).

7004886-6 | Blood Pressure Increased, Carotid Artery Occlusion, Condition Aggravated, Coronary Artery Occlusion, Device Occlusion, Loss Of Consciousness, Myocardial Infarction, Peripheral Arterial Occlusive Disease
Patient was taking Plavix (View Usage). Patient experienced the following unwanted or unexpected effects: blood pressure increased, carotid artery occlusion, condition aggravated, coronary artery occlusion, device occlusion, loss of consciousness, myocardial infarction, peripheral arterial occlusive disease on Sep 07, 2010 from UNITED STATES Additional patient health information: Male patient , 53 years of age, weighting 146.8 lb, . Plavix dosage: . During the same period patient was treated with VALIUM (View Valium Review and Valium Label ), KLONOPIN (View Klonopin Review and Klonopin Label ), CRESTOR (View Crestor Review and Crestor Label ), FISH OIL (View Fish Oil Review and Fish Oil Label ), NITROGLYCERIN (View Nitroglycerin Review and Nitroglycerin Label ), CORADOL (View Coradol Review and Coradol Label ). Patient was hospitalized.

7004884-2 | Anaemia, Haemarthrosis, International Normalised Ratio Increased, Melaena
Adverse event was reported on Sep 09, 2010 by a Female patient taking Plavix (View Usage) (Dosage: ) . Location: FRANCE , 76 years of age, Patient had the following side effects: anaemia, haemarthrosis, international normalised ratio increased, melaena. During the same period patient was treated with PREVISCAN (View Previscan Review and Previscan Label ), GLUCOPHAGE (View Glucophage Review and Glucophage Label ), ESOMEPRAZOLE MAGNESIUM (View Esomeprazole Magnesium Review and Esomeprazole Magnesium Label ), FLUDEX (View Fludex Review and Fludex Label ), OLMESARTAN MEDOXOMIL (View Olmesartan Medoxomil Review and Olmesartan Medoxomil Label ), ELISOR (View Elisor Review and Elisor Label ), AMAREL (View Amarel Review and Amarel Label ), CORDARONE (View Cordarone Review and Cordarone Label ). Patient was hospitalized.

7004865-9 |
on Sep 16, 2010 Female patient from AUSTRALIA , 87 years of age, was treated with Plavix (View Usage). . Plavix dosage: .

7004859-3 | Toxic Epidermal Necrolysis
on Sep 09, 2010 Female patient from JAPAN , 65 years of age, was diagnosed with stent placement and was treated with Plavix (View Usage). Patient experienced the following unwanted or unexpected effects: toxic epidermal necrolysis. Plavix dosage: . During the same period patient was treated with CEFZON (View Cefzon Review and Cefzon Label ).

7001106-3 | Hypochromic Anaemia
Patient was taking Plavix (View Usage). Patient had the following side effects: hypochromic anaemia on Sep 08, 2010 from SWEDEN Additional patient health information: Male patient , 70 years of age, . Plavix dosage: . During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), RANITIDINE (View Ranitidine Review and Ranitidine Label ). Patient was hospitalized.

7001097-5 | Atrioventricular Block Second Degree
Adverse event was reported on Sep 08, 2010 by a Male patient taking Plavix (View Usage) (Dosage: ) was diagnosed with arteriosclerosis obliterans and. Location: JAPAN , 82 years of age, After Plavix was administered, patient had the following side effects: atrioventricular block second degree. During the same period patient was treated with PARIET (View Pariet Review and Pariet Label ). Patient was hospitalized.

7000946-4 | Chronic Obstructive Pulmonary Disease, Condition Aggravated
on Sep 08, 2010 Male patient from UNITED STATES , 85 years of age, was treated with Plavix (View Usage). Patient experienced the following unwanted or unexpected effects: chronic obstructive pulmonary disease, condition aggravated. Plavix dosage: . Patient was hospitalized.

6992544-3 | Arthropathy, Electromechanical Dissociation, Myocardial Infarction, Post Procedural Haemorrhage
on Sep 12, 2010 Female patient from UNITED STATES , 80 years of age, was treated with Plavix (View Usage). Patient had the following side effects: arthropathy, electromechanical dissociation, myocardial infarction, post procedural haemorrhage. Plavix dosage: .

6992450-4 | Abdominal Distension, Gastrointestinal Haemorrhage, Haematemesis, Mallory-weiss Syndrome, Off Label Use
Patient was taking Plavix (View Usage). After Plavix was administered, patient had the following side effects: abdominal distension, gastrointestinal haemorrhage, haematemesis, mallory-weiss syndrome, off label use on Sep 08, 2010 from SWEDEN Additional patient health information: Male patient , 65 years of age, . Plavix dosage: . Patient was hospitalized.

6992323-7 | Fatigue, Furuncle, Gastrooesophageal Reflux Disease, Headache, Nausea, Weight Decreased
Adverse event was reported on Aug 31, 2010 by a Male patient taking Plavix (View Usage) (Dosage: ) . Location: UNITED STATES , 69 years of age, weighting 132.3 lb, Patient experienced the following unwanted or unexpected effects: fatigue, furuncle, gastrooesophageal reflux disease, headache (What is headache?), nausea (What is nausea?), weight decreased. During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), METOPROLOL TARTRATE (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ), ROSUVASTATIN CALCIUM (View Rosuvastatin Calcium Review and Rosuvastatin Calcium Label ), RANITIDINE (View Ranitidine Review and Ranitidine Label ), MULTI VITAMINS (View Multi-vitamins Review and Multi-vitamins Label ), COENZYME Q10 (View Coenzyme Q10 Review and Coenzyme Q10 Label ), ALBUTEROL (View Albuterol Review and Albuterol Label ), OXYGEN (View Oxygen Review and Oxygen Label ).

6988406-8 | Coronary Artery Restenosis
on Sep 09, 2010 Male patient from JAPAN , 63 years of age, weighting 158.7 lb, was diagnosed with angina unstable and was treated with Plavix (View Usage). Patient had the following side effects: coronary artery restenosis. Plavix dosage: . During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), AMARYL (View Amaryl Review and Amaryl Label ), NU LOTAN (View Nu-lotan Review and Nu-lotan Label ), CONIEL (View Coniel Review and Coniel Label ), DOXAZOSIN MESYLATE (View Doxazosin Mesylate Review and Doxazosin Mesylate Label ), ZYLORIC ^FRESENIUS^ (View Zyloric ^fresenius^ Review and Zyloric ^fresenius^ Label ).

6988347-6 |
on Sep 09, 2010 Male patient from UNITED STATES , 58 years of age, was treated with Plavix (View Usage). . Plavix dosage: .

6987835-6 | Cerebrovascular Accident, Hemiparesis, Influenza Like Illness, Memory Impairment, Respiratory Failure, Respiratory Tract Infection, Speech Disorder, Weight Increased
Patient was taking Plavix (View Usage). Patient experienced the following unwanted or unexpected effects: cerebrovascular accident, hemiparesis, influenza like illness, memory impairment, respiratory failure, respiratory tract infection, speech disorder, weight increased on Sep 02, 2010 from UNITED STATES Additional patient health information: Male patient , 45 years of age, . Plavix dosage: . During the same period patient was treated with OXYMETAZOLINE HCL (View Oxymetazoline Hcl Review and Oxymetazoline Hcl Label ), METOPROLOL TARTRATE (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), LASIX (View Lasix Review and Lasix Label ). Patient was hospitalized.

6987832-0 | Dermatitis Exfoliative, Purpura
Adverse event was reported on Sep 06, 2010 by a Male patient taking Plavix (View Usage) (Dosage: ) was diagnosed with renal failure and. Location: ITALY , 63 years of age, Patient had the following side effects: dermatitis exfoliative, purpura. During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), TRIATEC (View Triatec Review and Triatec Label ), LASIX (View Lasix Review and Lasix Label ), SEACOR (View Seacor Review and Seacor Label ), KLACID (View Klacid Review and Klacid Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ).

6987811-3 | Oropharyngeal Pain
on Sep 07, 2010 Female patient from ITALY , 66 years of age, was diagnosed with cardiac pacemaker insertion and was treated with Plavix (View Usage). After Plavix was administered, patient had the following side effects: oropharyngeal pain. Plavix dosage: . During the same period patient was treated with TORVAST (View Torvast Review and Torvast Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), ASPIRIN (View Aspirin Review and Aspirin Label ). Patient was hospitalized.

6987804-6 | Enterocolitis Haemorrhagic, International Normalised Ratio Increased, Petechiae
on Aug 12, 2010 Male patient from SWITZERLAND , 72 years of age, weighting 126.3 lb, was diagnosed with atrial fibrillation (What is atrial fibrillation?), cardiac flutter and was treated with Plavix (View Usage). Patient experienced the following unwanted or unexpected effects: enterocolitis haemorrhagic, international normalised ratio increased, petechiae. Plavix dosage: . During the same period patient was treated with DEPAKENE (View Depakene Review and Depakene Label ), SINTROM (11 Mg/week The First Week And 7 Mg/week The Second Week) (View Sintrom Review and Sintrom Label ), CIPROFLOXACIN (View Ciprofloxacin Review and Ciprofloxacin Label ), NEXIUM (Increased To 40 Mg/day From 19-dec-2008) (View Nexium Review and Nexium Label ), IMIPENEM AND CILASTATIN SODIUM (View Imipenem And Cilastatin Sodium Review and Imipenem And Cilastatin Sodium Label ), ATORVASTATIN CALCIUM (View Atorvastatin Calcium Review and Atorvastatin Calcium Label ).

6981581-0 | Atrial Fibrillation
Patient was taking Plavix (View Usage). Patient had the following side effects: atrial fibrillation (What is atrial fibrillation?) on Aug 31, 2010 from GREECE Additional patient health information: Female patient , weighting 198.4 lb, was diagnosed with acute coronary syndrome, prophylaxis and. Plavix dosage: . During the same period patient was treated with LOPRESSOR (View Lopressor Review and Lopressor Label ), SALOSPIR (View Salospir Review and Salospir Label ), LIPITOR (View Lipitor Review and Lipitor Label ), CONTROLOC (View Controloc Review and Controloc Label ), CRESTOR (View Crestor Review and Crestor Label ). Patient was hospitalized.